1. Minke, AE et al. The Oxygenscan: A Rapid and Reproducible Test to Determine Patient-Specific, Clinically Relevant Biomarkers of Disease Severity in Sickle Cell Anemia, ASH_Paper_2360
  2. Ware RE, de Montalembert M, Tshilolo L, Abboud MR. Sickle cell disease. Lancet. 2017;390(10091):311-323. doi:10.1016/S0140-6736(17)30193-9.
  3. Eaton WA, Bunn HF. Treating sickle cell disease by targeting HbS polymerization. Blood. 2017;129(20):2719-2726. doi:10.1182/blood-2017-02-765891.
  4. Paikari A, Sheehan VA. Fetal haemoglobin induction in sickle cell disease. Br J Haematol. 2018;180(2):189-200. doi:10.1111/bjh.15021.
  5. Morris CR, Suh JH, Hagar W, et al. Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease. Blood. 2008;111(1):402-410. doi:10.1182/blood-2007-
  6. Bessis M, Feo C, Jones E, Nossal M. Adaptation of the Ektacytometer to Automated Continuous pO2 Changes: Determination of Ervthrocvte Deformabilitv in Sickling Disorders. Cytometry. 1983;3(4):296-299
  7.  Osmotic Gradient Ektacytometry Cincinatti Children’s Hospital Case study
  8. Da Costa, L et al.  Diagnostic tool for red blood cell membrane disorders: Assessment of a new generation ektacytometer (Abstract)
  9. Minke AE Rab et al. Rapid and reproducible characterization of sickling during automated deoxygenation in sickle cell disease patients, Article to be published in the American Journal of Hematology
  10. Minke AE Rab et al. Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry,  Jove Video